Grunelabs in PORTUGAL
We are INNOVATION
Grunelabs Pharmaceutical Laboratory LDA is the second plant of the Grüne Group, owner of the first medical cannabis pharmaceutical company to settle in Uruguay in February 2015.
GrüneLabs Portugal, as it is known, exceeds Uruguay’s production capacity by 10 times with products for dermatological, neurological and veterinary treatments in addition to its main product Meroflex (R) now in a 100% organic version.
Located in the central area of Portugal, GrüneLabs has geographical advantages as it is 248 km away from Lisbon, 268 km away from Porto and 386 km from Madrid, important entry gates to Europe.
GrüneLabs Portugal is an entire pharmaceutical complex located in the Soalheira industrial zone, within the Gardunha Sul Industrial Park, at Serra da Gardunha. It has its own tajamar in addition to state water, 4500 m2 of high-tech polycarbonate stoves and future GMP facilities with state-of-the-art pharmaceutical laboratories for the purposes of processing and developing drugs with cannabinoids.
On August 7, 2020, INFARMED, National Authority for Medicines and Health Products, authorized Grunelabs Portugal to grow, manufacture, import and export the species of cannabis sativa L.
Cannabis has been used for therapeutic purposes for more than 4,000 years.